Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Endomar is a herbal dietary supplement developed by Omnifarma Kiev, specifically formulated to support and normalize the functional state of the thyroid gland. Its primary active components include extracts of *Potentilla alba* (White Cinquefoil), *Alpinia galanga* (Greater Galangal), and *Glycyrrhiza glabra* (Licorice). *Potentilla alba* is recognized in traditional medicine for its thyrotropic properties, containing elemental iodine, tannins, and flavonoids that help regulate thyroid hormone levels and improve the structure of thyroid tissue. *Alpinia galanga* provides anti-inflammatory and antioxidant effects, while *Glycyrrhiza glabra* acts as an adaptogen and anti-inflammatory agent, supporting the endocrine system. The supplement is indicated for individuals with hypothyroidism, hyperthyroidism, autoimmune thyroiditis, and euthyroid goiter to maintain hormonal balance and thyroid health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Endomar.